Sorenson was diagnosed Wednesday with stage 2 pancreatic cancer, and the 60-year old executive will begin chemotherapy treatment next week, the company said. Surgery is planned for the end of 2019.
Sorenson said in a statement that the cancer was discovered early and does not appear to have spread. He said his medical team is "confident" a complete cure is a realistic outcome.
"Let me make one request, look ahead with me. We have great work underway at Marriott. I am as excited by what we can accomplish together as I have ever been," the CEO said in a statement.
Sorenson has been a part of Marriott's team since 1996. Under his leadership, the hotel chain finalized a $14-billion acquisition of rival Starwood Hotels & Resorts in 2016.
Why It's Important
Pancreatic cancer is one of the deadliest forms of cancer, Bloomberg said. Less than 7 percent of patients survive more than five years after the initial diagnosis, mostly due to the absence of early symptoms.
Marriott is scheduled to report its first-quarter results May 10 before the market open. The stock was up 1.54 percent at $139 at the time of publication Friday.
Marriott Announces Massive Expansion At Investor Day; RayJay Stays Bullish
Analyst: Alternative Accommodation Leaders Will Surpass Top Hotel Chains Volume By 2021
Photo by Sam.meyer.marton/Wikimedia.
See more from Benzinga
- WSJ: Facebook Looking To Make Cryptocurrency Push
- Report: Sinclair To Buy Regional Sports Networks From Disney
- Berkshire Hathaway Takes A Stake In Amazon
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.